Gaurav Aggarwal - 11 Jul 2023 Form 4 Insider Report for Unicycive Therapeutics, Inc. (UNCY)

Role: Director
Signature: /s/ Gaurav Aggarwal
Issuer symbol: UNCY
Transactions as of: 11 Jul 2023
Net transactions value: -$8,077,000
Form type: 4
Filing time: 13 Jul 2023, 20:42:48 UTC
Previous filing: 09 Mar 2023
Next filing: 07 Sep 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	UNCY	Common Stock	Conversion of derivative security		+3,470,152			3,470,152	11 Jul 2023	By Vivo Opportunity Fund Holdings, L.P.	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	UNCY	Series A-1 Preferred Stock	Conversion of derivative security	$8,077,000	-8,077	-100%	$1000.00^*	0	11 Jul 2023	Common Stock	59,961,729	$0.4900	By Vivo Opportunity Fund Holdings, L.P.	F1, F2
transaction	UNCY	Series A-2 Preferred Stock	Conversion of derivative security	$0	+13,429,000		$0.000000	13,429,000	11 Jul 2023	Common Stock	13,429,000		By Vivo Opportunity Fund Holdings, L.P.	F1, F2, F3
transaction	UNCY	Tranche A Warrants (right to buy)	Conversion of derivative security	$0	+12,802,388		$0.000000	12,802,388	11 Jul 2023	Series A-3 Preferred Stock	12,802,388	$0.5390	By Vivo Opportunity Fund Holdings, L.P.	F1, F2, F3, F4
transaction	UNCY	Tranche B Warrants (right to buy)	Conversion of derivative security	$0	+11,638,534		$0.000000	11,638,534	11 Jul 2023	Series A-4 Preferred Stock	11,638,534	$0.5929	By Vivo Opportunity Fund Holdings, L.P.	F1, F2, F3, F4
transaction	UNCY	Tranche C Warrants (right to buy)	Conversion of derivative security	$0	+18,621,655		$0.000000	18,621,655	11 Jul 2023	Series A-5 Preferred Stock	18,621,655	$0.7411	By Vivo Opportunity Fund Holdings, L.P.	F1, F2, F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On July 11, 2023, the 8,077 shares of Series A-1 Preferred Stock then held by Vivo Opportunity Fund Holdings, L.P. automatically converted into (i) 3,470,152 shares of Common Stock, (ii) 13,429,000 shares of Series A-2 Preferred Stock, (iii) Tranche A Warrants to purchase 12,802,388 shares of Series A-3 Preferred Stock, (iv) Tranche B Warrants to purchase 11,638,534 shares of Series A-4 Preferred Stock and (v) Tranche C Warrants to purchase 18,621,655 shares of Series A-5 Preferred Stock. The shares of Series A-1 Preferred Stock had no expiration date.
F2	Vivo Opportunity Fund Holdings, L.P. is the record holder of the securities. The Reporting Person is a managing member of Vivo Opportunity, LLC, which is the general partner of Vivo Opportunity Fund Holdings, L.P. The Reporting Person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.
F3	Each of the Series A-2 Preferred Stock, Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series A-5 Preferred Stock (collectively, the "Preferred Stock") is convertible into Common Stock on a one-for-one basis; however, the Preferred Stock is subject to blocking provisions which preclude such shares from being converted if such conversion would result in the holder obtaining greater than 9.99% of the Issuer's voting securities. The shares of Preferred Stock have no expiration date.
F4	The Tranche A Warrants, Tranche B Warrants and Tranche C Warrants are immediately exercisable for shares of Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series A-5 Preferred Stock, respectively, and will each expire upon the Issuer's satisfaction of certain milestones.